Gender-related differences in severe, early-onset chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 6, 2000, Pages 2152-2158

  Silverman, Edwin K ^a   Weiss, Scott T ^b   Drazen, Jeffrey M ^b   Chapman, Harold A ^b   Carey, Vincent ^b   Campbell, Edward J ^b   Denish, Paul ^b   Silverman, Rachel A ^b   Celedon, Juan C ^b   Reilly, John J ^b   Ginns, Leo C ^b   Speizer, Frank E ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; BRONCHODILATING AGENT;

ADULT; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING; SPIROMETRY;

EID: 0034518935     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.6.2003112     Document Type: Article

References (36)

1. Trends in COPD morbidity and mortality in the United States
2. Changes in risk factors: The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease
3. The health consequences of smoking: Chronic obstructive lung disease: A report of the Surgeon General
4. Changing smoking patterns and mortality from chronic obstructive pulmonary disease
5. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: Results from a Danish longitudinal population study
6. Increased susceptibility to lung dysfunction in female smokers
7. 1: New insight into gender differences
8. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease: Risk to relatives for airflow obstruction and chronic bronchitis
9. Bronchodilator responsiveness and serum total IgE levels in families of probands with severe early-onset COPD
10. Epidemiology standardization project
11. Standardization of spirometry: 1994 update
12. Reference spirometric values using techniques and equipment that meet ATS recommendations
13. Ventilatory functions of normal children and young adults - Mexican-American, white, and black: I. Spirometry
14. Changes in the normal maximal expiratory flow-volume curve with growth and aging
15. Spirometric reference value from a sample of the general U.S. population
16. Improved identification of antitrypsin phenotypes through isoelectric focusing with dithioerythritol
17. A family study of the variability of pulmonary function in alpha 1-antitrypsin deficiency: Quantitative phenotypes
18. Quantum proteolysis resulting from release of single granules by human neutrophils
19. The functional activity of alpha 1-proteinase inhibitor in bronchoalveolar lavage fluids from healthy human smokers and non-smokers
20. Reaction of serine proteases with aza-amino acid and aza-peptide derivatives
21. Fundamentals of biostatistics
22. Longitudinal data analysis using generalized linear models
23. Longitudinal data analysis for discrete and continuous outcomes
24. Regression analysis for correlated data
25. Prognosis in severe chronic obstructive pulmonary disease
26. Breathlessness in patients with severe chronic airflow limitation: Physiologic correlations
27. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD
28. Prognosis in severe chronic obstructive pulmonary disease
29. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population
30. Relationship between lung volume and tracheal area as assessed by acoustic reflection
31. Sex differences in mortality of people who visited emergency rooms for asthma and chronic obstructive pulmonary disease
32. Gender effect on prognosis of patients receiving long-term home oxygen therapy
33. Gender difference in airway hyperresponsiveness in smokers with mild COPD
34. Distribution of bronchial responsiveness in a general population: Effect of sex, age, smoking, and level of pulmonary function
35. Bronchodilator response in chronic obstructive pulmonary disease
36. Clinical interpretation of airway response to a bronchodilator: Epidemiologic considerations